Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,773 across all filing types
Latest filing 2024-01-02 Director's Dealing
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Evotec SE: Dr. Werner Lanthaler, sell
Director's Dealing Classification · 1% confidence The document explicitly contains the header "Directors’ Dealings" and details a transaction (sell) by a "person discharging managerial responsibilities" (Dr. Werner Lanthaler, Member of the managing body) involving company shares. This directly matches the definition for Director's Dealing, which corresponds to the filing code DIRS.
2024-01-02 English
Evotec SE: Dr. Werner Lanthaler, sell
Director's Dealing Classification · 1% confidence The document explicitly states 'Directors’ Dealings' at the top and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. Section 4 details the 'Nature of the transaction' as 'Disposal' by 'Dr. Werner Lanthaler', who is a 'Member of the managing body'. This content directly matches the definition for Director's Dealing.
2024-01-02 English
Evotec SE: Dr. Werner Lanthaler, sell
Director's Dealing Classification · 1% confidence The document explicitly contains the header "Directors’ Dealings" and details a transaction (Disposal) by a "person discharging managerial responsibilities" (Dr. Werner Lanthaler, Member of the managing body) involving the issuer's shares. This directly matches the definition for Director's Dealing (DIRS). The document structure is a formal notification of insider trading activity.
2024-01-02 English
Evotec SE: Dr. Werner Lanthaler, sell
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. Section 1 identifies the person (Dr. Werner Lanthaler, Member of the managing body), and Section 4 details the transaction, specifically a 'Disposal' of shares. This content directly matches the definition for Director's Dealing, which corresponds to the filing code DIRS.
2024-01-02 English
Evotec SE: Dr. Werner Lanthaler, sell
Director's Dealing Classification · 1% confidence The document is explicitly titled 'Directors’ Dealings' and contains a 'Notification and public disclosure of transactions by persons discharging managerial responsibilities'. It details the name of the person (Dr. Werner Lanthaler), their position ('Member of the managing body'), and the nature of the transaction ('Disposal' of shares, including price and volume). This directly matches the definition for Director's Dealing (DIRS). The document length is short, but the content is the primary disclosure itself, not an announcement of a report.
2024-01-02 English
Update of the Declaration of Conformity with the German Corporate Governance Code for the Year 2023 (January 2024)
Governance Information Classification · 1% confidence The document is titled "Update of the Declaration of Conformity with the German Corporate Governance Code." It explicitly discusses adherence (or deviation) from specific recommendations (G.6 and G.10) of the German Corporate Governance Code (AktG). This content directly relates to the company's internal rules, board structure, and governance practices, making it a Governance Information document. It is not a general Annual Report (10-K), an Earnings Release (ER), or a Dividend Notice (DIV). The classification code CGR (Governance Information) is the most appropriate fit.
2024-01-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.